Fig. 4From: Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasmaPerturbation plot for effect of factors on: (A) retention time (VAL) and (B) resolution, where line (A) is % MeOH and line (B) is flow rateBack to article page